Cargando…

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment

Lenvatinib is an emerging multi-kinase inhibitor with a preferential anti-angiogenic activity, which has shown efficacy in the treatment of renal cell carcinoma, differentiated thyroid cancer and hepatocellular carcinoma. It inhibits vascular endothelial growth factor receptor family (VEGFR1–3), fib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capozzi, Monica, De Divitiis, Chiara, Ottaiano, Alessandro, von Arx, Claudia, Scala, Stefania, Tatangelo, Fabiana, Delrio, Paolo, Tafuto, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502442/ https://www.ncbi.nlm.nih.gov/pubmed/31118801 http://dx.doi.org/10.2147/CMAR.S188316

Ejemplares similares

Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms
por: von Arx, Claudia, et al.
Publicado: (2019)

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report
por: De Divitiis, Chiara, et al.
Publicado: (2015)

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms
por: Tafuto, Salvatore, et al.
Publicado: (2019)

Natural killer cells activity in a metastatic colorectal cancer patient with complete and long lasting response to therapy
por: Ottaiano, Alessandro, et al.
Publicado: (2017)

Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study
por: von Arx, Claudia, et al.
Publicado: (2020)

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples
por: Capozzi, Monica, et al.
Publicado: (2018)

Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020)

Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
por: De Divitiis, C., et al.
Publicado: (2016)

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

Malignant Sinonasal Tumors: Update on Histological and Clinical Management
por: Bracigliano, Alessandra, et al.
Publicado: (2021)

Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Evaluation of Tumor Response after Short-Course Radiotherapy and Delayed Surgery for Rectal Cancer
por: Rega, Daniela, et al.
Publicado: (2016)

Study of Ras Mutations’ Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients
por: Napolitano, Maria, et al.
Publicado: (2015)

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Evaluation of MGMT Gene Methylation in Neuroendocrine Neoplasms
por: Della Monica, Rosa, et al.
Publicado: (2022)

Is immunotherapy in the future of therapeutic management of sarcomas?
por: Clemente, Ottavia, et al.
Publicado: (2021)

Posterior HOX genes and HOTAIR expression in the proximal and distal colon cancer pathogenesis
por: Tatangelo, Fabiana, et al.
Publicado: (2018)

Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical Models
por: Wang, Mingxun, et al.
Publicado: (2023)

A Metabolomics-Based Screening Proposal for Colorectal Cancer
por: Troisi, Jacopo, et al.
Publicado: (2022)

Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
por: Marretta, Antonella Lucia, et al.
Publicado: (2021)

Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model
por: Suzuki, Kensuke, et al.
Publicado: (2022)

Aberrant Expression of Long Non Coding RNA HOTAIR and De-Regulation of the Paralogous 13 HOX Genes Are Strongly Associated with Aggressive Behavior of Gastro-Entero-Pancreatic Neuroendocrine Tumors
por: Di Mauro, Annabella, et al.
Publicado: (2021)

MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report
por: Petrillo, Mario, et al.
Publicado: (2015)

LIN28A: A multifunctional versatile molecule with future therapeutic potential
por: Wu, Kenneth, et al.
Publicado: (2022)

Assessing response to neo-adjuvant therapy in locally advanced rectal cancer using Intra-voxel Incoherent Motion modelling by DWI data and Standardized Index of Shape from DCE-MRI
por: Petrillo, Antonella, et al.
Publicado: (2018)

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Multidisciplinary Management of Retroperitoneal Sarcoma: Diagnosis, Prognostic Factors and Treatment
por: Carbone, Fabio, et al.
Publicado: (2021)

Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis
por: Marretta, Antonella Lucia, et al.
Publicado: (2023)

CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR
por: Circelli, Luisa, et al.
Publicado: (2016)

Multitargeting strategy using lenvatinib and golvatinib: Maximizing anti-angiogenesis activity in a preclinical cancer model
por: Nakazawa, Youya, et al.
Publicado: (2015)

Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models
por: Enomoto, Keisuke, et al.
Publicado: (2021)

Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting
por: Granata, Vincenza, et al.
Publicado: (2020)

Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types
por: Scognamiglio, Giosuè, et al.
Publicado: (2016)

Versatile Link: Present & Future
por: VASEY, Francois
Publicado: (2014)

Characterization of KRAS Mutational Regression in Oligometastatic Patients
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17vg9ofl01i421rksur0s74kto